Q2 2026 saw strong Medicaid and Medicare duals performance, offset by Marketplace losses due to adverse member mix and risk adjustment items. Full-year EPS guidance was raised to at least $5.25, with 2026 as a trough year for Medicaid margins and optimism for 2027 margin recovery.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.